| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |